Spin-Out Company Gains Approval for New Clinical Manufacturing Site

The contract research and manufacturing organisation Molecular Profiles Ltd, which spun out from the Laboratory of Biophysics and Surface Analysis in the School of Pharmacy, has opened the doors of its new facility following a successful inspection from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The Nottingham-based pharmaceutical production site will give drug development companies across the world access to state-of-the-art clinical manufacturing capabilities. Designed to handle a range of non-sterile dosage forms such as solids, liquids, semi-solids and inhaled products, the investment adds six GMP suites, new laboratories and a dedicated clinical packing area to support clients’ Phase I and II clinical trial projects. The facility also allows for the manufacture of highly potent compounds up to OEB 4 level with manufacturing batch scale of up to 30kg.

Click here for full story -> www.molprofiles.co.uk/about-us/news/approval-for-new-clinical-manufacturing-site/